Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  allodepleted T cell immunotherapeutic ATIR101
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
Status: Not yet active
Phase: Phase III
Type: Prevention, Treatment
Age: 18 to 70
Trial IDs: CR-AIR-009, NCI-2017-01213, 2016-004672-21, NCT02999854
Start Over